Source Bioscience Limited
Source Bioscience Limited
Source BioScience is a trusted, international provider of integrated state of the art Laboratory Services and Products. Headquartered in Nottingham, UK with locations in Cambridge, Rochdale, Ireland and San Diego, USA. ISO 15189, GCP and GMP accredited, ISO9001:2008 certified licensed by the Human Tissue Authority and registered with the Care Quality Commission. Source BioScience is a provider of genomics services including next-generation and sanger sequencing, outsourced and manufactured stability storage at ICH and custom conditions, healthcare diagnostic services. Many solutions. One Source.
Financial Snapshot
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Amanda Louise Barlow | Finance Director | 27/09/2023 | British | 51 years |
| Jay Charles Lecoque | Chairman | 24/11/2016 | American | 62 years |
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Sourcebio International Limited | Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors | 20/09/2016 | United Kingdom |
Financial Accounts
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
All present and future freehold or leasehold land and all intellectual property pursuant to clause 3...
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 13/01/2025 | Confirmation Statement | Confirmation Statement With Updates | View (4 pages) |
| 12/10/2024 | Accounts | Accounts With Accounts Type Full | View (23 pages) |
| 09/01/2024 | Confirmation Statement | Confirmation Statement With Updates | View (4 pages) |
| 18/12/2023 | Mortgage | Mortgage Charge Part Both With Charge Number | View (1 page) |
| 02/10/2023 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 02/10/2023 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 10/06/2023 | Accounts | Accounts With Accounts Type Full | View (23 pages) |